[250 Pages Report] Global Live Cell RNA Detection’ demand is anticipated to be valued at US$ 2,631.8 Million in 2022, forecast to grow at a CAGR of 8.4% to be valued at US$ 6,404.2 Million from 2022 to 2032. Growth is attributed to the increasing funding by the various regulatory bodies and governments globally.
| Report Attribute | Details |
|---|---|
| Growth Rate (2016 to 2021) | 8.5% CAGR |
| Expected Market Value (2022) | US$ 2,631.8 Million |
| Anticipated Forecast Value (2032) | US$ 6,404.2 Million |
| Projected Growth Rate (2022 to 2032) | 8.4% CAGR |
RNA plays an important role in cell and tissue development as well as disease progression thus it is considered to be a major target for analysis of various diseases and disorders. In RNA detection, the study gets done to understand the gene expression patterns and determine the roles of genomic elements in cellular function and dysfunction. In live cell RNA detection, a study of the live cell gets done to understand that how one cell within a population responds to its environment.
In live cell detection various techniques used to detect specific mRNA and microRNA in live cells while leaving the cells undisturbed and intact for further analysis. It also allows dissection of cell in RNA metabolism, RNA transcription, post-transcriptional processing, post-transcriptional regulations, nuclear export and RNA decay.
The growing adoption of high-content screening techniques in drug discovery and rising incidence of cancer primarily drives the market for live cell imaging. In addition, the growth in research funding and rising government funding and investment in regenerative medicine research will also support the market growth in the coming years.
On the other hand, the lack of skilled personnel to perform the detection is expected to hamper the growth of Live Cell RNA Detection Market over the analysis period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing research and development activities in molecular diagnostics sector and increasing availability of various new methodology and techniques are the major factors that are expected to boost the growth of the live cell RNA detection market during the forecast period.
Factors such as the increasing applications of RNA detection techniques in the genetic disorder detection and the increasing prevalence of cancer diseases are expected to propel the growth of the live cell RNA detection market over the analysis period.
The advantages of live cell RNA detection over the conventional techniques as conventional techniques failed to provide important spatial, temporal information, also anticipated to propel the demand for the live cell RNA detection and boost the growth of the global live cell RNA detection market over the forecast period. The funding by the various regulatory bodies and governments also expected to bolster the growth of the global live cell RNA detection market.
The high cost of reagents and devices required for live cell RNA detection is one of the major factors that is expected to hinder the growth of the live cell RNA detection market during the forecast period.
In addition, the stringent rules and regulatory guidance by the U.S. Food and Drug Administration (FDA), may also hinder the growth of the global live cell RNA detection market.
Moreover, the lack of skilled personnel to perform the detection, and high-content screening systems are also expected to impede the growth of the global live cell RNA detection market during the analysis period.
Principal Consultant
In terms of regional platform, North America holds the largest market share in Live Cell RNA Detection market. The region is expected to surge at over 35.0% share from 2022 to 2032.
North America is expected to fuel the Live Cell RNA Detection market, attributed to the developed laboratory infrastructure and availability of skilled personnel in the region.
According to Future Market Insights, Europe is expected to hold significant growth opportunities for Live Cell RNA Detection, and is expected to reach at a share of 29.0% in 2022.
Europe is expected to witness a significant market growth, owing to the increasing research and development activities along with government support and funding in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to Future Market Insights, Asia-Pacific is expected to grow with lucrative growth opportunities for Live Cell RNA Detection Market, and is expected to reach at a significant share of 20.3% in 2022.
Asia-Pacific region accounts for a significant share in Live Cell RNA Detection Market, attributed to the factors such as the government initiatives for research on stem cell therapy, the rising prominence of regenerative medicine research, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.
According to Future Market Insights, Middle East & Africa is expected to provide significant growth opportunities for Live Cell RNA Detection Market, and is expected to reach at a share of 10.3% in 2022.
The developing Live Cell RNA Detection market in the Middle East & Africa is expected to aid in flourishing market during the forecast period, owing to increasing awareness about Live Cell RNA Detection in the region.
There are many prominent market players in the Live Cell RNA Detection Market such as CytoSMART Technologies, INNOMED GmbH, Algorithmic Biologics, Phiab, uFluidix, JPK Instruments AG, and Tzar Labs, among others, that are working hand-in-hand to provide the best-in-class Live Cell RNA Detection for enhancing the global arena. However, there are many global start-ups in the Live Cell RNA Detection Market, that are stepping forward in matching the requirements of the Live Cell RNA Detection domain.
Some of the key participants present in the global Live Cell RNA Detection market include Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., MilliporeSigma, Promega Corporation, Biomol GmbH, Advanced Cell Diagnostics, Inc. and Qiagen Diagnostics, Nikon, and Bruker Corporation, among others.
Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., and MilliporeSigma account for a considerable market size, several regional level players are also operating across key growth regions, particularly in North America.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.4% from 2022 to 2032 |
| Market Value in 2022 | US$ 2,631.8 Million |
| Market Value in 2032 | US$ 6,404.2 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled | Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., MilliporeSigma, Promega Corporation, Biomol GmbH, Advanced Cell Diagnostics, Inc. and Qiagen Diagnostics, Nikon, and Bruker Corporation, among others. |
| Customization | Available Upon Request |
FMI projects the global Live Cell RNA Detection market to expand at an 8.4% value CAGR by 2032
North America is expected to be the most opportunistic Live Cell RNA Detection market, expanding at a 35.0% market share
Merck KGaA, BioTek Instruments, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., and MilliporeSigma are some prominent Live Cell RNA Detection players
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Techniques
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Techniques, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Techniques, 2022-2032
5.3.1. Linear Oligonucleotide Probe
5.3.2. Linear FRET Probe
5.3.3. Autoligation FRET Probe
5.3.4. Molecular Beacon
5.3.5. MS2-GFP
5.3.6. Bgl-mCherry
5.3.7. lN-GFP
5.3.8. PUM-HD
5.3.9. Spinach RNA Tracking System
5.4. Y-o-Y Growth Trend Analysis By Techniques, 2017-2021
5.5. Absolute $ Opportunity Analysis By Techniques, 2022-2032
6. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Diagnostics
6.3.2. Research and Development
6.3.3. Drug Discovery
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
7.3.1. Biotechnology Companies
7.3.2. Academic Institutes
7.3.3. Clinical Research Organizations
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Techniques
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Techniques
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Techniques
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Techniques
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Techniques
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Techniques
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of APAC
12.2.2. By Techniques
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Techniques
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. MEA Live Cell RNA Detection Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Techniques
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Techniques
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Live Cell RNA Detection Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Techniques
14.1.2.2. By Application
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Techniques
14.2.2.2. By Application
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Techniques
14.3.2.2. By Application
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Techniques
14.4.2.2. By Application
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Techniques
14.5.2.2. By Application
14.5.2.3. By End User
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Techniques
14.6.2.2. By Application
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Techniques
14.7.2.2. By Application
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Techniques
14.8.2.2. By Application
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Techniques
14.9.2.2. By Application
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Techniques
14.10.2.2. By Application
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Techniques
14.11.2.2. By Application
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Techniques
14.12.2.2. By Application
14.12.2.3. By End User
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Techniques
14.13.2.2. By Application
14.13.2.3. By End User
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Techniques
14.14.2.2. By Application
14.14.2.3. By End User
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Techniques
14.15.2.2. By Application
14.15.2.3. By End User
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Techniques
14.16.2.2. By Application
14.16.2.3. By End User
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Techniques
14.17.2.2. By Application
14.17.2.3. By End User
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Techniques
14.18.2.2. By Application
14.18.2.3. By End User
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Techniques
14.19.2.2. By Application
14.19.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Techniques
15.3.3. By Application
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Merck KGaA
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. BioTek Instruments, Inc.
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Thermo Fisher Scientific, Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Agilent Technologies Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. MilliporeSigma
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Promega Corporation
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Biomol GmbH
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Advanced Cell Diagnostics, Inc.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Qiagen Diagnostics
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Roche Holding AG
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Live Cell RNA Detection Market
